6 insiders reported 13 Form 4 transactions for Nexalin Technology, Inc. (NXL) over the past 18 months (most recent 2025-09-30). Recent activity: Owens David (Chief Medical Officer) Buy 36,459 shares, Hu Ben (Director) Buy 36,459 shares, OSSER LEONARD (Insider) Buy 83,333 shares, Elson Marilyn (Insider) Buy 83,333 shares, Kazden Alan (Director) Buy 36,459 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-09-30 | Owens David | Chief Medical Officer | Buy | 36,459 | $0 |
| 2025-09-30 | Hu Ben | Director | Buy | 36,459 | $0 |
| 2025-09-30 | OSSER LEONARD | Insider | Buy | 83,333 | $0 |
| 2025-09-30 | Elson Marilyn | Insider | Buy | 83,333 | $0 |
| 2025-09-30 | Kazden Alan | Director | Buy | 36,459 | $0 |
| 2025-03-13 | Shelton Carolyn Hamby | Sr. VP - Quality, Regulatory | Buy | 6,000 | $13,200 |
| 2025-02-10 | Shelton Carolyn Hamby | Senior VP | Buy | 24,000 | $20,400 |
| 2025-02-05 | Owens David | Chief Medical Officer | Buy | 1,000 | $3,100 |
| 2025-02-04 | Owens David | Chief Medical Officer | Buy | 1,000 | $2,980 |
| 2025-01-29 | Owens David | Chief Medical Officer | Buy | 1,000 | $2,750 |
| 2025-01-29 | Owens David | Chief Medical Officer | Buy | 1,500 | $4,050 |
| 2025-01-24 | Owens David | Chief Medical Officer | Buy | 2,000 | $5,000 |
| 2025-01-24 | Owens David | Chief Medical Officer | Buy | 1,000 | $2,700 |
Source: SEC Form 4 filings · as of 2025-09-30